26 Jul WuXi Advanced Therapies
Dr. Jason King, Associate Director Business Development
Oct. 11 | 3:00pm | Oxford Biomedica Ballroom
WuXi Advanced Therapies, a global Contract Testing Development and Manufacturing Organization (CTDMO), is the advanced therapies business unit of WuXi AppTec and offers integrated platforms to transform the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies for customers worldwide. WuXi ATU’s technologies, automation platforms, and service solutions advance preclinical research and accelerate the timeline to GMP manufacture, while integrated GMP manufacturing and testing platforms reduce time to market, maintaining high titres, high levels of quality assurance, and full regulatory compliance. Ultimately, WuXi ATU’s complete end-to-end solutions support pioneering companies to deliver breakthrough cell and gene therapies to the patients who need them.